logo

LIVN

LivaNova·NASDAQ
--
--(--)
--
--(--)

LIVN fundamentals

LivaNova (LIVN) Revenue Breakdown: Q3 2025 Business & Regional Performance
LivaNova (LIVN) reported total revenue of 357.75M USD in Q3 2025, with its core business segment Cardiac Surgery contributing 56.80%. Regionally, United States remained the largest market, accounting for 53.23% of total revenue. Explore LivaNova's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data